http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10143066

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 2625
issn 1479-6694
1744-8301
issueIdentifier 25
pageRange 2615-2625
publicationName Future oncology (London, England)
startingPage 2615
bibliographicCitation Fang A, Zhou S, Su X, Liu C, Chen X, Wan Y, Lei X, Xie L, Jia Y, Wang W, Yang L, Song X, Yao Y. RAMP3 is a prognostic indicator of liver cancer and might reduce the adverse effect of TP53 mutation on survival. Future Oncology. 2018 Oct;14(25):2615–25. doi: 10.2217/fon-2018-0296.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_55fd7daca1b4985064b9770efa3aa0ac
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_46ff4faa0a6735c8611504da5b4277a9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_18441c82901ba273d29b2f0baef24c34
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1b9267e5a1f806296ada5a4768b3c4a6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_73b5d18c783b7255459046b19004658e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4f2fe5f440ab73ab61a72d7fc09c9a7b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7787-8722
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bd969031998671155a15f1d81488a462
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c8c0ba0c909e6053e0be22dec00656e6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4cc5ea9f4ea875e6ea1eb7c0ad629994
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c4b34b1eb012b2af372d69544cb77d8f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_812388f9c4539af64f97e56e1478b157
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_39588f0f92f33b1bb720295867f06786
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dca97f2364a55af88e27dcf9928846d9
date 201810
identifier https://pubmed.ncbi.nlm.nih.gov/29882679
https://doi.org/10.2217/fon-2018-0296
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32856
https://portal.issn.org/resource/ISSN/1744-8301
https://portal.issn.org/resource/ISSN/1479-6694
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title RAMP3 is a prognostic indicator of liver cancer and might reduce the adverse effect of TP53 mutation on survival
discusses http://id.nlm.nih.gov/mesh/M0024671
http://id.nlm.nih.gov/mesh/M0541649
http://id.nlm.nih.gov/mesh/M0024670
http://id.nlm.nih.gov/mesh/M0486780
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D009154
http://id.nlm.nih.gov/mesh/D058264Q000502
http://id.nlm.nih.gov/mesh/D016159Q000235
http://id.nlm.nih.gov/mesh/D006528Q000401
http://id.nlm.nih.gov/mesh/D008113Q000401
hasSubjectTerm http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D008113Q000235
http://id.nlm.nih.gov/mesh/D011379
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D058264Q000235
http://id.nlm.nih.gov/mesh/D019175
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D006528Q000737
http://id.nlm.nih.gov/mesh/D058264Q000032
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D006528Q000235
http://id.nlm.nih.gov/mesh/D008113Q000737
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D008099Q000737
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8352
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_52a517e173e6fa70285ded085be0d86f
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_263764e67c04546fb3aa289e01575531
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7998

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID10268
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7157

Total number of triples: 64.